Personalis, Inc. revenue
Personalis, Inc.'s revenue was $69.6m in fiscal 2025, down 17.7% on the year before. Since fiscal 2017 ($9.4m) it has grown at a compound 28.5% a year. Over the last twelve months it was $69.7m.
Revenue history
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 38 | 65 | 79 | 85 | 65 | 73 | 85 | 70 | 70 |
| Growth on the year before | — | +302.2% | +72.6% | +20.6% | +8.7% | −23.9% | +13.0% | +15.2% | −17.7% | — |
| Gross profit | −2 | 12 | 22 | 20 | 32 | 13 | 18 | 27 | 16 | 9 |
| Gross margin | −24.9% | 31.3% | 33.9% | 25.6% | 37.0% | 20.5% | 24.8% | 31.7% | 22.7% | 12.7% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Personalis, Inc. | $69.7m | -13.3% | 1.2% |
| Exagen Inc. | $71.1m | 20.8% | 10.3% |
| Burning Rock Biotech Ltd | $75.1m | 4.7% | — |
| Codexis, Inc. | $77.7m | 35.9% | -7.8% |
| 908 Devices Inc. | $60.8m | 13.4% | 7.5% |
| Precipio, Inc. | $60.8m | 29.5% | 43.6% |
Compare with peers
- Exagen Inc. revenue
- Burning Rock Biotech Ltd revenue
- Codexis, Inc. revenue
- 908 Devices Inc. revenue
- Precipio, Inc. revenue
Head to head: PSNL vs XGNBNR vs PSNLCDXS vs PSNLMASS vs PSNL
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies